Nurses' experiences of their decision-making process when participating in clinical trials during the 2014-2016 West African Ebola crisis
© 2020 Wiley Periodicals LLC..
OBJECTIVE: Due to the absence of a licenced vaccine or drug for treatment of Ebola patients during the 2014-2016 West Africa outbreak, frontline nurses were at increased risk of exposure. Hence, they were prioritized to participate in clinical trials to receive experimental therapeutics. To our knowledge no study has explored the nurses' experiences of their decision-making process when volunteering in clinical trials using unproven agents, which is the purpose of this qualitative study.
METHODS: This study, part of a larger Ebola study, thematically analyzed the interview data of nine nurses recruited from Sierra Leone, Guinea and Liberia; of which four joined a convalescent plasma trial and five a vaccine trial.
RESULTS: In their decision-making process to partake in a clinical trial, nurses identified two distinct decision points: the initial commitment followed by the point of no return when they presented themselves to participate. Each of these decisions were influenced by risk versus benefits calculations, and contextual factors.
CONCLUSION: Results showed the need for more health education and communication around the unproven agents in order for nurses to make informed decisions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Public health nursing (Boston, Mass.) - 38(2021), 1 vom: 27. Jan., Seite 40-46 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nguyen, David [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical trial |
---|
Anmerkungen: |
Date Completed 13.10.2021 Date Revised 13.10.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/phn.12822 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316799831 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316799831 | ||
003 | DE-627 | ||
005 | 20231225161847.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/phn.12822 |2 doi | |
028 | 5 | 2 | |a pubmed24n1055.xml |
035 | |a (DE-627)NLM316799831 | ||
035 | |a (NLM)33111332 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nguyen, David |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nurses' experiences of their decision-making process when participating in clinical trials during the 2014-2016 West African Ebola crisis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.10.2021 | ||
500 | |a Date Revised 13.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 Wiley Periodicals LLC. | ||
520 | |a OBJECTIVE: Due to the absence of a licenced vaccine or drug for treatment of Ebola patients during the 2014-2016 West Africa outbreak, frontline nurses were at increased risk of exposure. Hence, they were prioritized to participate in clinical trials to receive experimental therapeutics. To our knowledge no study has explored the nurses' experiences of their decision-making process when volunteering in clinical trials using unproven agents, which is the purpose of this qualitative study | ||
520 | |a METHODS: This study, part of a larger Ebola study, thematically analyzed the interview data of nine nurses recruited from Sierra Leone, Guinea and Liberia; of which four joined a convalescent plasma trial and five a vaccine trial | ||
520 | |a RESULTS: In their decision-making process to partake in a clinical trial, nurses identified two distinct decision points: the initial commitment followed by the point of no return when they presented themselves to participate. Each of these decisions were influenced by risk versus benefits calculations, and contextual factors | ||
520 | |a CONCLUSION: Results showed the need for more health education and communication around the unproven agents in order for nurses to make informed decisions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Ebola virus outbreak | |
650 | 4 | |a clinical trial | |
650 | 4 | |a convalescent plasma | |
650 | 4 | |a decision-making process | |
650 | 4 | |a nursing care | |
650 | 4 | |a vaccines | |
700 | 1 | |a Arnaert, Antonia |e verfasserin |4 aut | |
700 | 1 | |a Pringle, John |e verfasserin |4 aut | |
700 | 1 | |a Ponzoni, Norma |e verfasserin |4 aut | |
700 | 1 | |a Kouyaté, Sekou |e verfasserin |4 aut | |
700 | 1 | |a Fansia, Nahal |e verfasserin |4 aut | |
700 | 1 | |a Nouvet, Elysée |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Public health nursing (Boston, Mass.) |d 1993 |g 38(2021), 1 vom: 27. Jan., Seite 40-46 |w (DE-627)NLM013907751 |x 1525-1446 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2021 |g number:1 |g day:27 |g month:01 |g pages:40-46 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/phn.12822 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 38 |j 2021 |e 1 |b 27 |c 01 |h 40-46 |